Valuation GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:00 2025-07-18 EDT			5-day change	1st Jan Change
1,348.00 ^GBX	-4.60%		-4.30%	+0.11%

07-18	US FDA advisers recommend against Otsuka's PTSD combination treatment	RE
07-18	Health Care Declines as Traders Hedge on Growth Views - Health Care Roundup	DJ

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	66,801	80,458	58,381	59,112	54,944	54,478	-	-
Change	-	20.44%	-27.44%	1.25%	-7.05%	-0.85%	-	-
Enterprise Value (EV) ¹	87,581	100,296	75,578	74,152	68,039	68,294	65,853	63,041
Change	-	14.52%	-24.65%	-1.89%	-8.24%	0.37%	-3.58%	-4.27%
P/E ratio	11.8x	18.6x	3.93x	11.9x	21.3x	9.56x	8.55x	7.95x
PBR	4.58x	5.34x	5.47x	4.4x	4.02x	3.7x	3.07x	2.59x
PEG	-	-0.8x	0x	-0.2x	-0.4x	0x	0.7x	1.07x
Capitalization / Revenue	1.96x	2.36x	1.99x	1.95x	1.75x	1.71x	1.62x	1.55x
EV / Revenue	2.57x	2.94x	2.58x	2.45x	2.17x	2.14x	1.96x	1.79x
EV / EBITDA	9.19x	8.85x	7.23x	6.37x	6.36x	6.35x	5.64x	5.08x
EV / EBIT	9.83x	11.4x	9.27x	8.44x	7.44x	7.19x	6.38x	5.72x
EV / FCF	16.2x	22.6x	12.1x	13.6x	13x	14.9x	10.1x	8.95x
FCF Yield	6.17%	4.42%	8.28%	7.36%	7.67%	6.72%	9.88%	11.2%
Dividend per Share ²	1	1	0.6125	0.58	0.61	0.6506	0.6916	0.7349
Rate of return	5.96%	4.98%	4.26%	4%	4.53%	4.83%	5.13%	5.45%
EPS ²	1.426	1.082	3.662	1.216	0.632	1.411	1.577	1.695
Distribution rate	70.1%	92.4%	16.7%	47.7%	96.5%	46.1%	43.8%	43.4%
Net sales ¹	34,099	34,114	29,324	30,328	31,376	31,946	33,594	35,159
EBITDA ¹	9,530	11,330	10,449	11,635	10,693	10,751	11,680	12,399
EBIT ¹	8,906	8,806	8,151	8,786	9,148	9,500	10,317	11,028
Net income ¹	5,749	4,385	14,956	4,928	2,575	5,656	6,343	6,755
Net Debt ¹	20,780	19,838	17,197	15,040	13,095	13,816	11,374	8,562
Reference price ²	16.78	20.08	14.38	14.50	13.46	13.48	13.48	13.48
Nbr of stocks (in thousands)	3,982,185	4,006,383	4,060,999	4,076,145	4,080,519	4,041,410	-	-
Announcement Date	2/3/21	2/9/22	2/1/23	1/31/24	2/5/25	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	9.56x	2.14x	6.35x	4.83%	73.24B
ELI LILLY AND COMPANY	36.13x	11.98x	27.23x	0.77%	693B
JOHNSON & JOHNSON	14.63x	4.31x	11.78x	3.15%	394B
ABBVIE INC.	27.14x	6.49x	13.73x	3.45%	334B
NOVO NORDISK A/S	15.94x	5.78x	11.57x	3.18%	287B
ROCHE HOLDING AG	14.37x	3.52x	8.72x	3.82%	259B
NOVARTIS AG	16.56x	4.4x	10.31x	3.49%	223B
ASTRAZENECA PLC	21.78x	4.08x	12x	2.32%	215B
MERCK & CO., INC.	10.26x	3.33x	7.2x	4.02%	201B
AMGEN INC.	22.54x	5.77x	11.13x	3.25%	158B
Average	18.89x	5.18x	12.00x	3.23%	283.82B
Weighted average by Cap.	22.16x	6.46x	14.88x	2.74%